SCHEMBL25462168

SCHEMBL25462168

c1ccc2nc(-c3nnnc4c3sc3ccccc34)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.38
▸ NPC1 O15118 8/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HSD17B10 Q99714 4/20 0.38
▸ AR P10275 4/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ LIMK1 P53667 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ TP53 P04637 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25461812 0.82 LIMK1 (0.51) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL25462167 0.78 LIMK1 (0.38) RAB9ANPC1KDM4ECYP1A2LIMK1
SCHEMBL25461799 0.78 RAB9A (0.38) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL25461698 0.75 RAB9A (0.42) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL25462165 0.75 KDM4E (0.40) RAB9ANPC1KDM4ECYP3A4CYP2C19
SCHEMBL25461872 0.73 RAB9A (0.43) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL15537126 0.72 AR (0.46) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL25462254 0.71 NPC1 (0.47) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL25461813 0.71 RAB9A (0.37) RAB9ANPC1KDM4EALDH1A1HSD17B10
SCHEMBL25461730 0.70 RAB9A (0.40) RAB9ANPC1KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 — — US disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 RAB9A 756/4885NPC1 1557/4885KDM4E 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback